$5.060
+0.364 (+7.20%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Entrada Therapeutics Inc (TRDA) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting TRDA is Sell.
Entrada Therapeutics Inc (TRDA) 20-Day simple moving average is 4.79, while Entrada Therapeutics Inc (TRDA) share price is $—, making it Buy.
Entrada Therapeutics Inc (TRDA) 60-Day simple moving average is 6.11, while Entrada Therapeutics Inc (TRDA) share price is $—, making it Sell.
Technical Analysis for TRDA
AI Technical TRDAAs of 2026-11-03, the technical board for Entrada Therapeutics Inc (TRDA) reads sell: 3 indicators are flashing buy, 6 are indicating sell, and 4 are neutral. Price at $5.06 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 43.754, MACD stands at -0.297 (Sell), Stochastic %K stands at 52.709, Stochastic %D stands at 58.983 and CCI stands at -16.583.
TRDA trades below the 60-day SMA (6.11) and below the 200-day SMA (8.65). Immediate resistance sits at Classic R1 5.12, then R2 5.56. Support sits at Classic S1 4.25, then S2 3.81.
Entrada Therapeutics Inc (TRDA) Support & Resistance Level
Entrada Therapeutics Inc (TRDA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 43.754 |
| STOCHk_14_3_3 | 52.709 |
| STOCHd_14_3_3 | 58.983 |
| CCI_20 | -16.583 |
| AO_5_34 | -0.561 |
| MOM_10 | -0.140 |
| MACD_12_26_9 | -0.297 |
Entrada Therapeutics Inc (TRDA) Relative Strength Index (RSI_14) is 43.754, creating a Neutral signal.
Entrada Therapeutics Inc (TRDA) Stochastic %K is 52.709, creating a Neutral signal.
Entrada Therapeutics Inc (TRDA) Stochastic %D is 58.983, creating a Neutral signal.
Entrada Therapeutics Inc (TRDA) CCI_20 is -16.583, creating a Neutral signal.
Entrada Therapeutics Inc (TRDA) Awesome Oscillator (AO) is -0.561, creating a Sell signal.
Entrada Therapeutics Inc (TRDA) Momentum (MOM) is -0.140, creating a Sell signal.
Entrada Therapeutics Inc (TRDA) Moving Average Convergence Divergence (MACD) is -0.297, creating a Sell signal.
Entrada Therapeutics Inc (TRDA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.803 | Buy |
| MA_10 | 4.682 | Buy |
| MA_20 | 4.787 | Buy |
| MA_60 | 6.110 | Sell |
| MA_200 | 8.648 | Sell |
| MA_250 | 8.929 | Sell |
Entrada Therapeutics Inc (TRDA) 5-Day simple moving average is 4.803, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Buy.
Entrada Therapeutics Inc (TRDA) 10-Day simple moving average is 4.682, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Buy.
Entrada Therapeutics Inc (TRDA) 20-Day simple moving average is 4.787, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Buy.
Entrada Therapeutics Inc (TRDA) 60-Day simple moving average is 6.110, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Sell.
Entrada Therapeutics Inc (TRDA) 200-Day simple moving average is 8.648, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Sell.
Entrada Therapeutics Inc (TRDA) 250-Day simple moving average is 8.929, while Entrada Therapeutics Inc (TRDA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.